Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ohana Biosciences, a clinical-stage biotechnology company pioneering reproductive medicine through an industry-first platform of sperm-based technologies, today announced…
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create…
OSAKA, Japan & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced FETROJA® (cefiderocol) is now available in…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
Light-Activated AU-011 Holds Significant Potential as a First Line Treatment for Choroidal Melanoma CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a clinical-stage biopharmaceutical…
LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #AAD2020—Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that results from its CTP-543 Phase 2 dose-ranging trial in…
MONTREAL–(BUSINESS WIRE)–The venture capital fund AmorChem II is very proud to announce the financing of a new university project focusing…
MENLO PARK, Calif.–(BUSINESS WIRE)–Intersect ENT, Inc. (NASDAQ:XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions,…
– Publication Affirms Rocket’s Approach to Treating Fanconi Anemia – NEW YORK–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage…